Navigation Links
Reportlinker Adds Small Molecule Kinase Inhibitors Report
Date:9/8/2009

The Truth Behind Inadequate Reimbursement of New Cancer Drugs II-8

Manufacturers Find Risk-Sharing, Rebating, & Contracting As Effective Antidotes II-9

Financial-based Contracts II-10

Performance-based Contracts II-10

Reimbursements Issues in UK II-10

On Cards: Reimbursement for Pfizer's Sutent in UK II-10

Reimbursement for GlaxoSmithKline's Tyverb Hits a Roadblock in UK II-10

Reimbursements Issues in the United States II-10

Medicare Shifts Oral Anti Cancer Drugs to Higher Drug Formulary Tiers II-10

Implications for the Patient II-11

Table 4: Oral Anticancer Drugs Covered in Medicare Part D Plans (2009): Percentage Share Breakdown of Plans, Which Require Prior Authorization, & Plans, Which Have Quantity Limits, by Drug Brand (includes corresponding Graph/Chart) II-12

Table 5: Oral Anticancer Drugs Covered in Medicare Part D Plans (2009): Breakdown of Cost Sharing Range by Drug Brand II-12

Table 6: Placement of Select Oral Anticancer Drugs in the Drug Tier System Covered in Medicare Part D Plans for the Year 2009) II-13

Transition of Oral Anti-Cancer Drugs to Higher Cost Sharing

Tiers: Gleevec A Case in Point: II-13

Table 7: Percentage Breakdown of Beneficiaries Prescribed Gleevec and Covered Under Standalone Prescription Drug Plans (PDPs) by Tier For Years 2006 through 2009 (includes corresponding Graph/Chart) II-13

Table 8: Change in Percentage of Co-insurance Amount for Leading Oral Cancer Therapies Under Standalone Prescription Drug Plans (PDPs) (During 2006 to 2009) - For Gleevec,

Tarceva, Sutent, and Tykerb (includes corresponding Graph/Chart) II-14

Emergence of Newer Side effects: An Area of Concern for Modern pKis II-14

Hsp90 Inhibitors: Hope for Cancer Patients Resistant to Kinase Inhibitor Drugs II-14

Noteworthy Issues Related to Major Drugs: An Evaluation of
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Reportlinker Adds Nanomedicine Report
2. Reportlinker Adds Proteomics: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
5. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
6. Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
7. Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
8. The Worlds Smallest Hero! Rexin-G, Targeted Therapy for Metastatic Cancers
9. AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer
10. Signostics Receives FDA Clearance for Worlds Smallest Ultrasound Product
11. PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Nueva Jersey , 22 de enero de ... Biomedical Research abre hoy su llamada a nominaciones para ... investigación científica ha hecho, o tiene el potencial para ... humana. Las nominaciones se aceptarán hasta el 15 de ...
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... focused on advanced wound care, announces that AMNIOEXCEL® ... have been added to the Premier, Inc. Regenerative ... opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Accurately Measure Cardiac Output ... (CPX), WASHINGTON, September 19 Cheetah Medical Inc.,developers of ... at HFSA the results of the study,"Markers of ventilatory inefficiency ... led by Dr. Jon Myers of Stanford University and the ...
... Perkins ... Strong Endorsement of Technology Pioneer at Forefront of Developing No- ... Compromise Biofuels, EMERYVILLE, ... biofuels, today,announced that it closed the first tranche of its $70 million Series ...
... Sept. 19 CuraGen Corporation,(Nasdaq: CRGN ), ... that Timothy M. Shannon, M.D., has been appointed,President ... Armstrong. Dr. Armstrong will remain with the Company ... transition, and will continue on CuraGen,s,Board of Directors ...
Cached Biology Technology:Cheetah Medical's NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting 2Cheetah Medical's NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting 3Amyris Biotechnologies Announces $70 Million Series B Round 2CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer 2CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer 3CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer 4CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer 5
(Date:12/17/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) ... S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis" ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a totally ... for the first time a fingerprint sensor in its ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in this market ... applications. Chemical sensors help in recording of patient data ...
(Date:12/11/2014)... Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... addition of the "Biometrics Market in India 2015-2019" ... major trend emerging in this market is the adoption ... than one characteristic of an individual for verification and ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... the heels of a summit on managing extreme events held ... Academy of Sciences and the Willis Research Network, part of ... in the U.K., pledged to continue exploring activities aimed at ... events. Although 2011 has been a notable year for ...
... School of Medicine have demonstrated a method that enables ... X chromosome. The technology allows the rapid and highly ... X chromosome genes. The method, developed in cooperation ... the Oct. 2011 issue of Genomics . Senior ...
... Saranac Lake, N.Y. New research from the Trudeau Institute ... Cooper,s lab has discovered a connection between the development of ... disease. The new data will be published in the November ... (Vol. 187, Num. 10) and is available now online ahead ...
Cached Biology News:US science academy and global reinsurance broker spark 2US science academy and global reinsurance broker spark 3US science academy and global reinsurance broker spark 4Technology targets genetic disorders linked to X chromosome 2Trudeau Institute announces its latest discovery in the fight against tuberculosis 2
... Coated Capture Antibody: 12 x 8-well strips, 3 ... of 2X concentrate , Beta Amyloid 1-40 ... Lyophilized Standard Diluent: 3 mL , Primary Antibody: ... 30 microL of concentrate , OPD Substrate: 20 ...
Peptide Sequence: ovine COX-1 amino acids 272-282 (LMHYPRGIPPQ) To be used in conjunction with Cayman's COX-1 (ovine) polyclonal antiserum (Catalog No. 160108) to block protein-antibody complex f...
Laminin beta-1/gamma-1 (612C10)...
... Platypus Contact Printing Kit contains choice of Printing Surface ... Gold over Ti adhesion layer, 1 silicon wafer coated ... or 3 plain glass slides), PDMS Stamps (3 PDMS ... squares or 100 um x 10 mm or 200 ...
Biology Products: